Announcements
-
27-Jul-2018
The Board of Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company met today to approve financial results for the quarter ended June 30, 2018.
+
-
15-May-2018
Jubilant Life Sciences Ltd, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma Limited.
+
-
09-May-2018
The Board of Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company met today to approve financial results for the quarter and year ended March 31, 2018.
+
-
09-Apr-2018
Jubilant Bhartia Foundation in collaboration with The Schwab Foundation for Social Entrepreneurship, a sister organization of the World Economic Forum, announces opening of entries for the annual competition –Social Entrepreneur of the Year (SEOY) India Award 2018. The applications will be accepted till April 30, 2018.
+
-
09-Feb-2018
Jubilant Life Sciences Ltd, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma Limited, a material wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, has received Abbreviated New Drug Application (ANDA) final approval for Amantadine Hydrochloride Tablets, 100 mg, the generic version of Symmetrel® of Endo, which is indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. It is also indicated in the treatment of Parkinsonism and drug-induced extrapyramidal reactions.
+
-
30-Jan-2018
Jubilant Pharma Limited, a material wholly owned subsidiary of Jubilant Life Sciences Ltd, through one of its wholly owned subsidiaries, has received Abbreviated New Drug Application (ANDA) final approval.
+
-
17-Jan-2018
The Board of Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company met today to approve financial results for the quarter and nine months ended December 31, 2017.
+